Related references
Note: Only part of the references are listed.Treatment landscape of triple-negative breast cancer - expanded options, evolving needs
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of Breast Cancer
Dragana Kopanja et al.
CANCER RESEARCH (2022)
FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation
Hamadi Madhi et al.
ADVANCED SCIENCE (2022)
USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
Yueh-Te Lin et al.
CELLS (2022)
Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy
Chrisanta Harakandi et al.
BIOORGANIC CHEMISTRY (2021)
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
Mariana Paes Dias et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Advancing targeted protein degradation for cancer therapy
Brandon Dale et al.
NATURE REVIEWS CANCER (2021)
Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
Katarzyna Pogoda et al.
JOURNAL OF ONCOLOGY (2020)
Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
Si-Min Qi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
USP7 Is a Master Regulator of Genome Stability
Gabrielle J. Valles et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components
Monique B. Nilsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
Nadine M. Tung et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis
Xiaohong Xia et al.
CANCER LETTERS (2019)
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Blake E. Smith et al.
NATURE COMMUNICATIONS (2019)
Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP Inhibition
Pingping Fang et al.
MOLECULAR CANCER RESEARCH (2018)
The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
Shang Yao et al.
SEMINARS IN CANCER BIOLOGY (2018)
Regulation of the master regulator FOXM1 in cancer
Guo-Bin Liao et al.
CELL COMMUNICATION AND SIGNALING (2018)
Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases
Seemana Bhattacharya et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer
Jill J. J. Geenen et al.
CLINICAL PHARMACOKINETICS (2018)
Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis
Lijun Li et al.
Oncotarget (2017)
HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma
Omid Tavana et al.
NATURE MEDICINE (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Acetylation of FOXM1 is essential for its transactivation and tumor growth stimulation
Cuicui Lv et al.
ONCOTARGET (2016)
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Michael Zengerle et al.
ACS CHEMICAL BIOLOGY (2015)
Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
Michelle W. Wong-Brown et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Triple-negative breast cancer in African-American women: disparities versus biology
Eric C. Dietze et al.
NATURE REVIEWS CANCER (2015)
FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
Stefania Zona et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity
Jorg van Loosdregt et al.
IMMUNITY (2013)
The Forkhead Transcription Factor FOXM1 Controls Cell Cycle-Dependent Gene Expression through an Atypical Chromatin Binding Mechanism
Xi Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Mechanisms of resistance to therapies targeting BRCA-mutant cancers
Christopher J. Lord et al.
NATURE MEDICINE (2013)
Forkhead box proteins: tuning forks for transcriptional harmony
Eric W. -F. Lam et al.
NATURE REVIEWS CANCER (2013)
FOXM1: From cancer initiation to progression and treatment
Chuay-Yeng Koo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2012)
A Novel FoxM1-Caveolin Signaling Pathway Promotes Pancreatic Cancer Invasion and Metastasis
Chen Huang et al.
CANCER RESEARCH (2012)
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
Nu Zhang et al.
CANCER CELL (2011)
Multiple faces of FoxM1 transcription factor Lessons from transgenic mouse models
Tanya V. Kalin et al.
CELL CYCLE (2011)
Roles of HAUSP-mediated p53 regulation in central nervous system development
N. Kon et al.
CELL DEATH AND DIFFERENTIATION (2011)
Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2011)
Control of DNMT1 Abundance in Epigenetic Inheritance by Acetylation, Ubiquitylation, and the Histone Code
Christian Bronner
SCIENCE SIGNALING (2011)
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Jian Yuan et al.
CELL (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inactivation of HAUSP in vivo modulates p53 function
N. Kon et al.
ONCOGENE (2010)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
p53 negatively regulates expression of FoxM1
Bulbul Pandit et al.
CELL CYCLE (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pro-proliferative FoxM1 is a target of p53-mediated repression
A. M. Barsotti et al.
ONCOGENE (2009)
FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness
I-Ching Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Min Sup Song et al.
NATURE (2008)
Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression
Zheng Fu et al.
NATURE CELL BIOLOGY (2008)
Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes
Yongjun Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
p53 ubiquitination: Mdm2 and beyond
CL Brooks et al.
MOLECULAR CELL (2006)
Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: Implications for the regulation of the p53-MDM2 pathway
M Hu et al.
PLOS BIOLOGY (2006)
Forkhead box m1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase
IC Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Targeting the DNA repair defect of BRCA tumours
N Turner et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators
ML Major et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A dynamic role of HAUSP in the p53-Mdm2 pathway
MY Li et al.
MOLECULAR CELL (2004)
Mono-versus polyubiquitination: Differential control of p53 fate by Mdm2
MY Li et al.
SCIENCE (2003)
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
MY Li et al.
NATURE (2002)
Share Paper
